InvestorsHub Logo
Followers 826
Posts 119431
Boards Moderated 16
Alias Born 09/05/2002

Re: biopearl post# 12745

Wednesday, 11/26/2014 12:52:41 PM

Wednesday, November 26, 2014 12:52:41 PM

Post# of 20689
Teva's intention is to delay any FDA action by extending the review of the CP, but (as previously noted) I don't think it will work.

I don't think the CP supplement per se makes a sole MNTA approval more likely.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”